Liminatus Pharma, Inc. - Class A Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 14/08/2026 | Mar 2026Filed 14/08/2026 | Sep 2025Filed 14/11/2025 | Jun 2025Filed 14/08/2026 | Mar 2025Filed 14/08/2026 | Sep 2024Filed 14/11/2025 | Jun 2024Filed 14/11/2025 | Mar 2024Filed 14/11/2025 |
|---|---|---|---|---|---|---|---|---|
| −$1.4 | −$1.1 | −$1.8 | $0.1 | −$0.3 | −$0.6 | −$1 | −$1.8 | |
| −$0.03 | −$0.03 | −$0.07 | $0.00 | −$0.02 | −$0.03 | −$0.05 | −$2.47 | |
| 48 | 36 | 27 | 23 | 18 | 18 | 18 | 0 |
Trend